Viral anterior uveitis

Current Opinion in Ophthalmology

Volumn 22, Issue 6, 2011, Pages 483-488

  Jap, Aliza ^a,b   Chee, Soon Phaik ^a,c,d  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b CHANGI GENERAL HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

Author keywords

cytomegalovirus; hypertensive anterior uveitis; iris atrophy; rubella virus

Indexed keywords

ACICLOVIR; CURCUMIN; GANCICLOVIR; VALACICLOVIR;

AGE; ANTIVIRAL THERAPY; CATARACT; CHIKUNGUNYA ALPHAVIRUS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; GLAUCOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; IRIS ATROPHY; MYDRIASIS; NEPHROTOXICITY; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOPHAKIA; RELAPSE; REVIEW; RUBELLA VIRUS; SLIT LAMP; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VARICELLA ZOSTER VIRUS; VIRAL ANTERIOR UVEITIS; VIRAL EYE INFECTION;

HUMANS; UVEITIS, ANTERIOR;

EID: 80054937035     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32834be021     Document Type: Review

References (51)

1. Birnbaum AD, Little DM, Tessler HH, Goldstein DA. Etiologies of chronic anterior uveitis at a tertiary referral center over 35 years. Ocul Immunol Inflamm 2011; 19:19-25.
2. Chan SM, Gan KD, Weis E. Characteristics and predictors of recurrence of anterior and intermediate uveitis in a Canadian referral centre. Can J Ophthalmol 2010; 45:144-148.
3. Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center: analysis of 1916 patients. J Rheumatol 2009; 36:127-136.
4. Thygeson P, Hogan MI, Kimura SJ. Observations on uveitis associated with viral disease. Trans Am Ophthalmol Soc 1957-1958; 55:333-349.
5. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186:S3-S28. (Pubitemid 35178845)
6. Wong A, Tan KH, Tee CS, Yeo GS. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J 2000; 41:151-155.
7. Taechowisan T, Sutthent R, Louisirirotchanakul S, et al. Immune status in congenital infections by TORCH agents in pregnant Thais. Asian Pac J Allergy Immunol 1997; 15:93-97. (Pubitemid 27462565)
8. Tookey PA, Ades AE, Peckham CS. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child 1992; 67:779-783.
9. Gratacap-Cavallier B, Bosson JL, Morand P, et al. Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol 1998; 14:147-152. (Pubitemid 28138911)
10. Sengupta N, Breuer J. A global perspective of the epidemiology and burden of varicella-zoster virus. Curr Pediatr Rev 2009; 5:207-228.
11. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 2007; 55:173-183.
12. Van Boxtel LA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 2007; 114:1358-1362. (Pubitemid 47001492)
13. De Schryver I, Rozenberg F, Cassoux N, et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol 2006; 90:852-855. (Pubitemid 43973995)
14. Chee SP, Bacsal K, Jap A, et al. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 2008; 145:834-840.
15. De Visser L, Braakenburg A, Rothova A, de Boer JH. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol 2008; 146:292-297.
16. Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 2004; 138:46-54. (Pubitemid 38850248)
17. Ruokonen PC, Metzner S, Ucer A, et al. Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs? heterochromic cyclitis. Graefes Arch Clin Exp Ophthalmol 2010; 248:565-571.
18. Suzuki J, Goto H, Komase K, et al. Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. Graefes Arch Clin Exp Ophthalmol 2010; 248:1487-1491.
19. Van der Lelij A, Ooijman FM, Kijlstra A, Rothova A. Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases. Ophthalmology 2000; 107:1164-1170.
20. Sungur GK, Hazirolan D, Yalvac IS, et al. Incidence and prognosis of ocular hypertension secondary to viral uveitis. Int Ophthalmol 2010; 30:191-194.
21. Tugal-Tutkun I, Otük-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol 2010; 30:559-565.
22. Chee SP, Jap A. Presumed Fuchs heterochromic iridocyclitis and Posner- Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol 2008; 146:883-889.
23. Hwang YS, Shen CR, Chang SH, et al. The validity of clinical feature profiles for cytomegaloviral anterior segment infection. Graefes Arch Clin Exp Ophthalmol 2011; 249:103-110.
24. Goldstein DA, Mis AA, Oh FS, Deschenes JG. Persistent pupillary dilation in herpes simplex uveitis. Can J Ophthalmol 2009; 44:314-316.
25. Mahendradas P, Shetty R, Narayana KM, Shetty BK. In vivo confocal microscopy of keratic precipitates in infectious versus noninfectious uveitis. Ophthalmology 2010; 117:373-380.
26. Kanavi MR, Soheilian M, Naghshgar N. Confocal scan of keratic precipitates in uveitic eyes of various etiologies. Cornea 2010; 29:650-654.
27. Kanavi MR, Soheilian M, Yazdani S, Peyman GA. Confocal scan features of keratic precipitates in Fuchs heterochromic iridocyclitis. Cornea 2010; 29:39-42.
28. Miserocchi E, Waheed NK, Dios E, et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis. A clinical evaluation and comparison. Ophthalmology 2002; 109:1532-1537.
29. Yamamoto S, Pavan-Langston D, Tada R, et al. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol 1995; 119:796-798.
30. Lin P, Yoon MK, Chiu CS. Herpes zoster keratouveitis and inflammatory ocular hypertension 8 years after varicella vaccination. Ocul Immunol Inflamm 2009; 17:33-35.
31. Esmaeli-Gutstein B, Winkelman JZ. Uveitis associated with varicella virus vaccine. Am J Ophthalmol 1999; 127:733-734. (Pubitemid 29266758)
32. Naseri A, Good WV, Cunningham ET. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol 2003; 135:415-417. (Pubitemid 36279544)
33. Kezuka T, Sakai J, Minoda H, et al. A relationship between varicella-zoster virus-specific delayed hypersensitivity and varicella-zoster virus-induced anterior uveitis. Arch Ophthalmol 2002; 120:1183-1188. (Pubitemid 35034340)
34. Dastrup BT, Cantor L, Moorthy RS, et al. An unusual manifestation of herpes simplex virus-associated acute iris depigmentation and pigmentary glaucoma. Arch Ophthalmol 2011; 129:253-254.
35. Tugal-Tutkun I, Araz B, Taskapili M, et al. Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients. Ophthalmology 2009; 116:1552-1557.
36. Barequet IS, Li Q, Wang Y, et al. Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol 2000; 129:672-673. (Pubitemid 30323740)
37. Chee SP, Bacsal K, Jap A, et al. Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology 2007; 114:798-803. (Pubitemid 46483688)
38. Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology 2008; 115:292-297.
39. Herpetic Eye disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998; 339:300-306.
40. Uchoa UB, Rezende RA, Carrasco MA, et al. Long term acyclovir use to prevent recurrent ocular herpes simplex virus infection. Arch Ophthalmol 2003; 121:1702-1704. (Pubitemid 37517435)
41. Wilson SS, Fakioglu E, Herold BC. Novel approaches in fighting herpes simplex virus infections. Expert Rev Anti Infect Ther 2009; 7:559-568.
42. Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol 2010; 4:1201-1206.
43. Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol 2010; 94:1648-1652.
44. Hahné S, Macey J, van Binnendijk R, et al. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. Pediatr Infect Dis J 2009; 28:795-800.
45. Bouchenaki N, Herbort CP. Fluorescein angiographic findings and clinical features in Fuchs? uveitis. Int Ophthalmol 2010; 30:511-519.
46. Al-Mansour YS, Al-Rajhi AA, Al-Dhibi H, Abu El-Asrar AM. Clinical features and prognostic factors in Fuchs? uveitis. Int Ophthalmol 2010; 30:501-509.
47. Mahendradas P, Ranganna SK, Shetty R, et al. Ocular manifestations associated with Chikungunya. Ophthalmology 2008; 115:287-291. (Pubitemid 351163361)
48. Mahendradas P, Shetty R, Malathi J, Madhavan HN. Chikungunya virus iridocyclitis in Fuchs? heterochromic iridocyclitis. Indian J Ophthalmol 2010; 58:545-547.
49. De Groot-Mijnes JD, de Visser L, Zuurveen S, et al. Identification of new pathogens in the intraocular fluid of patients with uveitis. Am J Ophthalmol 2010; 150:628-636.
50. Shiraishi A, Hara Y, Takahashi M, et al. Demonstration of ?owl's eye? morphology by confocal microscopy in a patient with presumed cytomegalovirus corneal endotheliitis. Am J Ophthalmol 2007; 143:715-717. (Pubitemid 46452509)
51. Wertheim MS, Mathers WD, Planck SJ, et al. In vivo confocal microscopy of keratic precipitates. Arch Ophthalmol 2004; 122:1773-1781. (Pubitemid 39610501)